Collaboration Models That Work: How Academia, Big Pharma & Startups Are Co-Innovating In today’s fast-moving biotechnology landscape, breakthrough innovation rarely comes from one organisation alone. The most transformative discoveries, whether in gene therapies, AI-driven drug discovery, cell and gene manufacturing, or
EASEE4YOU Clinical Study Begins in the UK as GOSH Joins Evaluation of New Neurostimulation Therapy London, 11 Dec 2025: A major European clinical study, EASEE4YOU, is preparing to launch in the UK, with Great Ormond Street Hospital (GOSH) joining the international research effort. The study
Newcastle Launches the UK’s First National Centre for Neurotechnology and Neurorestoration United Kingdom - 03 Dec 2025: Experts from Newcastle Hospitals, in collaboration with Newcastle University, have established the National Centre for Neurotechnology and Neurorestoration, the UK’s first dedicated facility
UK and US Finalise Zero-Tariff Deal on Pharmaceuticals to Boost Investment and Market Access United Kingdom - 01 Dec, 2025: The United States and the United Kingdom have reached a landmark agreement that will eliminate tariffs on British pharmaceutical products and medical technologies, marking
The Evolving Regulatory Landscape: What MHRA and EMA Advancements Mean for Biotech Innovators The biotechnology industry is in a transformative phase, propelled by recent, forward-looking regulatory updates across the UK and EU that make it easier to develop, manufacture and bring novel therapies
UK–Canada Collaboration Advances New Anti-Biofilm Therapies United Kingdom - 25 Nov 2025: University of Cambridge spin-out BioTryp Therapeutics has joined forces with Montreal-based preclinical drug discovery research company, Intellisyn Pharma, to accelerate the development of next-generation
UK Government’s £55 Billion R&D Boost to Accelerate Healthcare Innovation London, 30 October 2025: The UK Government has announced a landmark £55 billion R&D funding allocation to strengthen the nation’s position as a global leader in science,
UK’s First MS Patient Receives CAR T Cell Therapy in Groundbreaking UCL Trial London, 24 Oct 2025: A patient with multiple sclerosis (MS) in the UK has become the first to receive CAR T cell therapy, an innovative treatment developed by researchers at
Ras Al Khaimah’s Flagship Investment & Business Event Returns for a Bigger 2nd Edition Ras Al Khaimah, UAE – The Ras Al Khaimah Investment & Business Summit (RAKIS) is set to return on November 19–20, 2025, at the Al Hamra International Exhibition & Conference
Eventum Orthopaedics Secures £3.8M to Revolutionise Knee Replacement Surgery 19 March, 2024: Leeds-based medtech startup, Eventum Orthopaedics, has secured £3.8 million in follow-on investment to expand its groundbreaking surgical device, QuadSense. Designed to enhance knee replacement procedures, QuadSense
University of Liverpool Launches AI-Powered Eye Cancer Bioresource to Advance Early Detection and Treatment 13 March, 2025: The University of Liverpool has introduced the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID)—a groundbreaking initiative aimed at improving early detection and treatment of rare eye
UK Government Backs AI Regulation Reforms in MedTech 10 March 2025: The UK Government has accepted the majority of recommendations from the Regulatory Horizons Council (RHC) regarding the regulation of artificial intelligence (AI) in medical devices, aiming to
ITK Engineering Expands into UK MedTech Market, Bringing Digital Engineering Excellence Denham, 7 March 2025 – ITK Engineering, a global technology firm and subsidiary of Robert Bosch, is expanding into the UK MedTech sector. With 30 years of expertise in software and
Ras Al Khaimah’s Real Estate Market Surges Amid Rising Demand & Investment 19 March 2025, Ras Al Khaimah: Ras Al Khaimah’s real estate sector is entering a dynamic phase of rapid expansion, driven by increasing demand, rising property values, and significant
Roche & Zealand Pharma Partner to Co-Develop Petrelintide as a Breakthrough Obesity Therapy Basel, 12 March 2025 – Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma (a Danish biotechnology research company) to co-develop and co-commercialise Zealand Pharma’s amylin
